Skip to content

Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients.

A Pre-Marketing, Prospective, Single-Site, Open-Label, Within-Subject, Actual-Use, Interventional Study of Acceptance and Performance With Experienced Adult Cochlear Implant Recipients Using the CP1110 Sound Processor Compared With the CP1000 Sound Processor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05080283
Acronym
PINNA
Enrollment
20
Registered
2021-10-15
Start date
2021-11-02
Completion date
2022-09-13
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Cochlear Implant Recipients

Brief summary

The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN 2'.

Detailed description

The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN 2'. This study will build on the evidence collected in previous Nucleus 7 Sound Processor take home studies and will also aim to confirm the in-booth performance of CP1110 and Nucleus 7 Sound Processors.

Interventions

DEVICECP1110 Sound Processor System with automated ForwardFocus On (SCAN 2 FF)

Sound Processor

DEVICENucleus 7 Sound Processor (model: CP1000) system

Sound Processor

DEVICECP1110 Sound Processor System with ForwardFocus Off (SCAN 2)

Sound Processor

Sponsors

Avania
CollaboratorINDUSTRY
Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective, pre-market, single-site, non-randomized.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Aged 18 years or older. 2. Post lingually deafened. 3. Implanted with the CI600 Series (CI612, CI632, CI622, CI624), CI500 Series (CI512, CI532, CI522) or Freedom Series (CI24RE(CA), CI24RE(ST), CI422). 4. At least 6 months experience with a cochlear implant. 5. At least 3 months experience with a Nucleus 7 (CP1000) Sound Processor 6. Able to score 30% or more at +15 SNR with CI alone on a sentence in babble test 7. Willingness to participate in and to comply with all requirements of the protocol. 8. Fluent speaker in English as determined by the investigator 9. Willing and able to provide written informed consent

Exclusion criteria

1. Additional disabilities that would prevent participation in evaluations. 2. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedures. 3. Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator. 4. Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. 5. Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation. 6. Currently participating, or participated in another interventional clinical study/trial in the past 30 days or if less than 30 days, the prior investigation was Cochlear sponsored and determined by the investigator to not impact clinical findings of this investigation.

Design outcomes

Primary

MeasureTime frameDescription
Speech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0Nrearhalf)6 monthsPaired difference in dB SRT (AuSTIN) between the CP1110 Sound Processor with automated ForwardFocus ON (SCAN 2 FF) and ForwardFocus OFF (SCAN 2) in 65 dB SPL S0Nrearhalf 4TB.

Secondary

MeasureTime frameDescription
Speech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0N3)6 monthsPaired difference in dB SRT (AuSTIN) between the CP1110 Sound Processor with automated ForwardFocus On (SCAN 2 FF) and ForwardFocus OFF (SCAN 2) in 65 dB SPL S0N3 Babble.
Adult Cochlear Implant Recipient Speech Perception in Quiet With the CP1110 Sound Processor and the Nucleus 7 Sound Processor6 monthsPaired difference in percentage CNC Words correct in quiet (50 dB) with the CP1110 Sound Processor and Nucleus 7 Sound Processor.
Adult Cochlear Implant Subjective Hearing Performance and Sound Quality With the CP1110 Sound Processor and Nucleus 7 Sound ProcessorBaseline (Nucleus 7) and Visit 2 (6 months, CP1110)Paired difference in Global Speech, Spatial and Qualities of Hearing Scale (SSQ12) scores after experience with the CP1110 Sound Processor and Nucleus 7 Sound Responses. SSQ12 have a minimum value of 0 and a maximum of 10, wherein a higher score means a better outcome.

Countries

Australia

Participant flow

Participants by arm

ArmCount
All Participants
All participants were assigned to CP1110 Sound Processor System with ForwardFocus On (SCAN), CP1110 Sound Processor System with ForwardFocus Off (SCAN) compared to the previously marketed Nucleus 7 Sound Processor (Model: CP1000) in a random order.
20
Total20

Baseline characteristics

CharacteristicAll Participants
Age, Continuous61 years
Age of onset of hearing loss21.4 years
STANDARD_DEVIATION 19.84
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Australia
20 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
13 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Speech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0Nrearhalf)

Paired difference in dB SRT (AuSTIN) between the CP1110 Sound Processor with automated ForwardFocus ON (SCAN 2 FF) and ForwardFocus OFF (SCAN 2) in 65 dB SPL S0Nrearhalf 4TB.

Time frame: 6 months

ArmMeasureGroupValue (MEAN)
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfSpeech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0Nrearhalf)CP1110 ForwardFocus On-10.34 dB SRT
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfSpeech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0Nrearhalf)CP1110 ForwardFocus Off-6.04 dB SRT
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfSpeech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0Nrearhalf)Difference between CP1110 ForwardFocus On and ForwardFocus off-4.30 dB SRT
Secondary

Adult Cochlear Implant Recipient Speech Perception in Quiet With the CP1110 Sound Processor and the Nucleus 7 Sound Processor

Paired difference in percentage CNC Words correct in quiet (50 dB) with the CP1110 Sound Processor and Nucleus 7 Sound Processor.

Time frame: 6 months

ArmMeasureGroupValue (MEAN)
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfAdult Cochlear Implant Recipient Speech Perception in Quiet With the CP1110 Sound Processor and the Nucleus 7 Sound ProcessorCP1110 Sound Processor60.40 percentage of correct words
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfAdult Cochlear Implant Recipient Speech Perception in Quiet With the CP1110 Sound Processor and the Nucleus 7 Sound ProcessorNucleus 7 Sound Processor56.80 percentage of correct words
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfAdult Cochlear Implant Recipient Speech Perception in Quiet With the CP1110 Sound Processor and the Nucleus 7 Sound ProcessorDifference between CP1110 and Nucleus 7 Sound Processor3.60 percentage of correct words
Secondary

Adult Cochlear Implant Subjective Hearing Performance and Sound Quality With the CP1110 Sound Processor and Nucleus 7 Sound Processor

Paired difference in Global Speech, Spatial and Qualities of Hearing Scale (SSQ12) scores after experience with the CP1110 Sound Processor and Nucleus 7 Sound Responses. SSQ12 have a minimum value of 0 and a maximum of 10, wherein a higher score means a better outcome.

Time frame: Baseline (Nucleus 7) and Visit 2 (6 months, CP1110)

ArmMeasureGroupValue (MEAN)
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfAdult Cochlear Implant Subjective Hearing Performance and Sound Quality With the CP1110 Sound Processor and Nucleus 7 Sound ProcessorCP1110 Sound Processor5.96 units on a scale
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfAdult Cochlear Implant Subjective Hearing Performance and Sound Quality With the CP1110 Sound Processor and Nucleus 7 Sound ProcessorNucleus 7 Sound Processor5.95 units on a scale
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfAdult Cochlear Implant Subjective Hearing Performance and Sound Quality With the CP1110 Sound Processor and Nucleus 7 Sound ProcessorDifference between CP1100 and Nucleus 7 Sound Processor0.01 units on a scale
Secondary

Speech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0N3)

Paired difference in dB SRT (AuSTIN) between the CP1110 Sound Processor with automated ForwardFocus On (SCAN 2 FF) and ForwardFocus OFF (SCAN 2) in 65 dB SPL S0N3 Babble.

Time frame: 6 months

ArmMeasureGroupValue (MEAN)
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfSpeech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0N3)CP1110 ForwardFocus On-8.35 dB SRT
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfSpeech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0N3)CP1110 ForwardFocus Off-4.16 dB SRT
Within-subject Comparison of CP1110 ForwardFocus On Versus ForwardFocus Off in S0NrearhalfSpeech Reception Thresholds (SRT) Assessed in Spatially Separated Speech and Noise (S0N3)Difference between CP1110 ForwardFocus On and ForwardFocus Off-4.18 dB SRT

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026